Probucol and statins for recent ischemic stroke
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether adding probucol to statin therapy can help people who recently had an ischemic stroke caused by hardened arteries. The goal is to see if this combination works better than statins alone for preventing future strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke in the last 30 days, confirmed by a brain scan.
- You are 18 years or older.
- Hardening of the arteries (atherosclerosis) was found in at least one major artery (like the neck, heart, or legs).
- You haven't taken probucol or other cholesterol-lowering drugs (except statins, ezetimibe, or PCSK9 inhibitors) in the 30 days before starting.
- You do not have atrial fibrillation, recent heart attack, severe liver or kidney problems, or a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the drug probucol can help people who recently had a stroke or mini-stroke caused by a narrowed artery in the brain or neck. It aims to reduce the risk of future strokes.
This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This study tests whether adding clopidogrel (a blood thinner) to atorvastatin or rosuvastatin (cholesterol-lowering drugs) helps people who had a first-time large-vessel ischemic stroke. It aims to find the best way to prevent another stroke.
This trial compares two treatments for people who recently had a stroke or TIA and have high cholesterol with artery plaque. Some participants will get a combination of two cholesterol-lowering medicines (statin and ezetimibe), while others will get only a statin.
This trial is testing whether a combination of two medicines—colchicine (an anti-inflammatory) and a low dose of rivaroxaban (a blood thinner)—can help prevent future heart attacks, strokes, or other blood vessel problems in people who recently had a stroke caused by a blood clot.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.